Studies on the once daily dosing immunosuppressive therapy of tacrolimus extended release and mycophenolate mofetil in maintenance kidney transplant patients

Trial Profile

Studies on the once daily dosing immunosuppressive therapy of tacrolimus extended release and mycophenolate mofetil in maintenance kidney transplant patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2014

At a glance

  • Drugs Mycophenolate mofetil (Primary)
  • Indications Transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top